An International Observational Study of Adults With Acute Infection

Part of paid clinical trials in Tucson, Arizona.

Sponsor
University of Minnesota
Study ID
NCT07069400
Status
Recruiting

Conditions

  • Infectious Disease

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • No intervention — OTHER
    This is an observational study

Study Details

Prospective, longitudinal studies of people with acute infections are essential to understand risk factors, clinical manifestations, pathobiology, and management strategies. Observational studies can provide data necessary to select interventions and strategies for testing in clinical trials and to develop key design features of trials. Observational studies can be particularly important for establishing an early knowledge base after emergence of a new pathogen, as illustrated by the recent emergence of influenza A (H1N1), SARS-CoV-2, and Mpox. This observational study protocol describes collection of data and biospecimens from sites across the world for characterizing acute infections in hospitalized patients. The protocol is designed to study respiratory infections, infections outside the respiratory tract, established infectious diseases, and emerging infectious diseases. Data generated in this study will be used to efficiently characterize acute infectious diseases and plan future clinical trials.

Key Dates

Start date
Aug 25, 2025
Status verified
Jun 2026
Primary completion
Jun 8, 2027
Completion
Jun 8, 2027

Study Design

Enrollment
1,500 participants (estimated)

Arms

  • Arm: Study group
    The study population includes adult patients admitted to a hospital with a suspected or confirmed acute infection.

Primary Outcome Measure

Day 28 Mortality [ Time Frame: Day 28 ]

Central Contacts

Locations (18)

FacilityCityStateZIPSite coordinators
Banner University Medical Center TucsonTucsonArizona85719
Nashville ICC
Stanford University Hospital & Clinics (Site 203-003)Palo AltoCalifornia94305
Nashville ICC
UCSF Medical Center (Site 203-001)San FranciscoCalifornia94143
Nashville ICC
Orlando VA Medical Center (074-032)OrlandoFlorida32827
Washington ICC
University of Illinois at Chicago (Site 008-012)ChicagoIllinois60612
Hennepin ICC
University of Kansas Medical Center (Site 080-044)Kansas CityKansas66160
Hennepin ICC
University of MinnesotaMinneapolisMinnesota55414
Cavan Reilly, PhD
Mayo Clinic (Site 054-001)RochesterMinnesota55905
Hennepin ICC
University of Nebraska Medical Center (Site 080-045)OmahaNebraska68198-5400
Hennepin ICC
Mount Sinai Medical Center (Site 301-012)New YorkNew York11234
New York ICC
New York University Langone Health (301-013)New YorkNew York10016
New York ICC
Duke University (301-006)DurhamNorth Carolina27710
New York ICC
Wake Forest Baptist Health (210-001)Winston-SalemNorth Carolina27157
Nashville ICC
Cleveland Clinic Foundation (Site 207-001)ClevelandOhio44195
Nashville ICC
Vanderbilt University Medical Center (Site 212-001)NashvilleTennessee37232
Nashville ICC
UT Southwestern Medical Center (084-001)DallasTexas75390
Washington ICC
Intermountain Medical Center (Site 211-001)MurrayUtah84107
Nashville ICC
West Virginia University Medicine (301-023)MorgantownWest Virginia26506
New York ICC

Find similar trials in Tucson, AZ

Related Studies